ZFGN = 0.99 US dollar
-0.17 USD (-17.172%)
change of stock price since yesterday
Shows the last deal stock price of Zafgen, Inc. in US dollar. Stock price of Zafgen, Inc. in US dollar from reliable databases. Information of stock prices is reference. 1 stock of Zafgen, Inc. falls by 0.17 US dollar. Zafgen, Inc. stock price went down. For 1 stock of Zafgen, Inc. now you need to give 0.99 US dollar.
Show:
to
Zafgen, Inc. share price in US dollar
A week ago, Zafgen, Inc. stock can be exchanged for 0.87 US dollar. Three months ago, Zafgen, Inc. stock can be exchanged for 0 US dollar. Six months ago, Zafgen, Inc. stock could be bought for 0 US dollar. The stock price of the Zafgen, Inc. in US dollar can be seen on the chart. The change of the stock price of Zafgen, Inc. in US dollar for the week is 13.47%. 0% per year - the change in the stock price of Zafgen, Inc..
If you have 9.90 US dollar, then in the British Virgin Islands you can get 10 stocks of Zafgen, Inc.. If you have 24.75 US dollar, then in the British Virgin Islands you can buy 25 stocks of Zafgen, Inc.. Stock quote converter now gives 49.50 US dollar for 50 stocks of Zafgen, Inc.. Today 100 stocks of ZFGN = 99 USD. Buying 250 stocks of Zafgen, Inc. costs 247.50 US dollar. Buying 500 stocks of Zafgen, Inc. costs 495 US dollar.
ZFGN stock price history
Date
Rate
Change
28/05/2020
0.99 USD
-0.17 ↓
27/05/2020
1.16 USD
0.01 ↑
26/05/2020
1.15 USD
0.06 ↑
22/05/2020
1.09 USD
0.22 ↑
21/05/2020
0.87 USD
-
1 stock of Zafgen, Inc. in US dollar is now on 28 May 2020 - 0.99 US dollar. 27 May 2020, 1 stock of Zafgen, Inc. = 1.16 US dollar. 26 May 2020, 1 stock of Zafgen, Inc. = 1.15 US dollar. The maximum stock quote of Zafgen, Inc. in US dollar in was on 27/05/2020. The minimum stock price of ZFGN/USD in was on 21/05/2020.
Zafgen, Inc.
Today's stock price of Zafgen, Inc. is 0.99 $. ZFGN stock price changed by -17.172% or -0.17 USD since last trading day. You can buy 100 ZFGN stocks for 99 US dollar or sell 50 ZFGN stocks for 49.50 US dollar.
Zafgen Inc is a biopharmaceutical company engaged in improving the health and well-being of patients affected by obesity and complex metabolic disorders. Its product candidate include Beloranib.
